SCHEMBL715412

SCHEMBL715412

CCCC[P+](C)(CCCC)CCCC.COS(=O)(=O)[O-]

nearest known ligand 0.41

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.41
TSHR P16473 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
EPHX2 P34913 1/20 0.41
BLM P54132 1/20 0.41
TP53 P04637 1/20 0.36
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
MMP13 P45452 3/20 0.35
MMP9 P14780 1/20 0.33
FUT7 Q11130 1/20 0.32
MMP1 P03956 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
FDPS P14324 1/20 0.31
MMP7 P09237 1/20 0.31
MMP12 P39900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL27994932 0.98 RECQL (0.39) RECQLTSHRGLAHPGDMAPK1
SCHEMBL27203256 0.94 RECQL (0.37) RECQLTSHRGLAHPGDMAPK1
SCHEMBL17102610 0.92 RECQL (0.47) RECQLTSHRGLAHPGDMAPK1
SCHEMBL4955999 0.92 RECQL (0.47) RECQLTSHRGLAHPGDMAPK1
Ammonia Solution, Strong SCHEMBL27730912 0.91 TP53 (0.39) RECQLTSHRGLAHPGDMAPK1
Sulfuric Acid SCHEMBL29270371 0.86 TP53 (0.41) RECQLTSHRGLAHPGDMAPK1
SCHEMBL17456606 0.84 DNM1 (0.48) RECQLTSHRGLAHPGDMAPK1
SCHEMBL1293511 0.84 TP53 (0.40) RECQLTSHRGLAHPGDMAPK1
SCHEMBL3043679 0.83 RECQL (0.47) RECQLTSHRGLAHPGDMAPK1
SCHEMBL6261279 0.81 RECQL (0.39) RECQLTSHRGLAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4721970-A1 BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE LAYER Henkel AG & Co. KGaA (DE) 2026-04-08 EP claimed
WO-2025242379-A1 BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-11-27 WO claimed
WO-2025228672-A1 TWO-COMPONENT (2K) CURABLE ADHESIVE COMPOSITION HENKEL AG & CO. KGAA (DE) 2025-11-06 WO claimed
WO-2025228674-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-11-06 WO claimed
EP-4644502-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM Henkel AG & Co. KGaA (DE) 2025-11-05 EP claimed
EP-4644500-A1 TWO-COMPONENT (2K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2025-11-05 EP claimed
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP claimed
WO-2025119646-A1 BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE HENKEL AG & CO. KGAA (DE) 2025-06-12 WO claimed
WO-2025118203-A1 BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE FILM ADHESIVE HENKEL AG & CO. KGAA (DE) 2025-06-12 WO claimed
WO-2025119658-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-06-12 WO claimed
US-7638636-B2 Phosphonium and imidazolium salts and methods of their preparation CYTEC TECHNOLOGY CORP. (US) 2009-12-29 US claimed
EP-1893716-A1 NOVEL WORKING MEDIA FOR REFRIGERATION PROCESSES Evonik Degussa GmbH (DE) 2008-03-05 EP claimed
EP-1587813-B1 PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION CYTEC CANADA INC (CA) 2007-10-03 EP claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006134015-A1 NOVEL WORKING MEDIA FOR REFRIGERATION PROCESSES EVONIK DEGUSSA GMBH (DE) 2006-12-21 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
US-20060264645-A1 Phosphonium and imidazolium salts and methods of their preparation CYTEC CANADA INC. (CA) 2006-11-23 US claimed
EP-1587813-A1 PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION Cytec Canada Inc. (CA) 2005-10-26 EP claimed
CN-1675230-A Phosphonium and imidazolium salts and methods for their preparation CYTEC CANADA INC (CA) 2005-09-28 CN claimed
WO-2004016631-A1 PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION CYTEC CANADA INC. (CA) 2004-02-26 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264645-A1 Phosphonium and imidazolium salts and methods of their preparation PIK3R5, PHOSPHO1, PNISR RECQL 140/4885TSHR 1922/4885GLA 4154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.